As an Ordinary Car Company, Tesla Cannot Compete
Last May we warned that shares of Tesla were in trouble. While the rest of the EV sector has grown a little, the once-innovative car maker has gone the other way.
The Big Secret on Wall Street (this week)
The Busted IPO With 10x Upside
In addition to its thriving e-commerce segment, this company has also created online grocery and restaurant delivery services and the largest domestic streaming service in its home country in southeast Asia.
More Important Than Any One Stock
Research suggests that this part of the investment puzzle can play a more crucial role in investors’ long-term success than which individual investments they own.
The Buyout Brothers’ Profit Machine
In this month’s issue, we focus on a serial buyer of businesses that for 40 years has been acquiring good companies and making them even better.
How Not to Lose $1.6 Million a Day
Financial history is littered with tales of foolish cash management that have destroyed trillions in shareholder value. Entrepreneur Michael Saylor has pioneered a strategy that could revolutionize corporate financial management and help companies avoid those costly mistakes.
Bulls Balls
For only the third time in history, a new energy drink has surpassed the billion-dollar mark in annual sales in the U.S. But this company is not only taking market share from its two main competitors but it’s expanding the size of the overall market.
Market Manias Can Make Fools of Us All
While the overall market continues to ride higher, there are signs beneath the surface that suggest things could begin to turn. Taking lessons from a legendary investor, we look at how to avoid getting caught up in the exuberance.
The Basement Experiment That Became a $2 Billion Best-Seller
In a world of constant change, one thing remains steady: Americans love for chocolate. Today we focus on the ultimate “forever stock.” Backed up by more than a century of brand power, this business will remain as relevant for our children and grandchildren as it was for our parents and grandparents.
The Time For Biotech Is Now
As a sector, biotech stocks perform differently than tech stocks, “forever stocks,” and certainly the blue chips… We asked biotech veteran Erez Kalir to explain, in his own words, how he finds the right stocks for our new advisory Biotech Frontiers.
Cashing In at the Courthouse
The “Fixer,” a leading global provider of litigation financing, funds lawsuits and takes a cut of the payout when it wins. This highly profitable and capital efficient business model can turn small investments into supersized returns.